Figure 2

Data distribution of measured SP-ELISA absorbances.
(a) Total IgM and (b) IgG titers in 126 MS patient sera detected by SP-ELISA, comparison between the antigen I(Glc), and the non-glucosylated analog I. (c) Total IgM and (d) IgG titers in 112 NBD sera detected by SP-ELISA, comparison between I(Glc) antigen and the non-glucosylated analog I. MS patient and NBD sera selected for the detailed analysis are marked as red dots and circles.